The Gross Margin of BioCryst Pharmaceuticals Inc (BCRX) is 97.23%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 97.23% |
| 2023-12-31 | 98.59% |
| 2022-12-31 | 97.56% |
| 2021-12-31 | 95.36% |
| 2020-12-31 | 90.45% |
| 2019-12-31 | 91.60% |
| 2018-12-31 | 97.58% |
| 2017-12-31 | 93.25% |
| 2016-12-31 | 89.77% |
| 2015-12-31 | 96.07% |